Sunrise Group Company Limited (SZSE:002752) acquired Taizhou Dachen Pharmaceutical Co., Ltd. in 2022. Taizhou Dachen Pharmaceutical generates an annual output of $58 million

Sunrise Group Company Limited (SZSE:002752) completed the acquisition of Taizhou Dachen Pharmaceutical Co., Ltd. in 2022.